Zdrowie i gospodarka · 28/03/2012
FDA Requests Public Comment on Proposed Collection of Financial Disclosure Information by Clinical Investigators
The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to financial disclosure by clinical investigators, as required by the Paperwork Reduction Act of 1995